Tidemark’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.42K Hold
56
﹤0.01% 613
2026
Q1
$4.83K Hold
56
﹤0.01% 558
2025
Q4
$4.89K Hold
56
﹤0.01% 504
2025
Q3
$3.21K Hold
56
﹤0.01% 568
2025
Q2
$3.31K Hold
56
﹤0.01% 570
2025
Q1
$4.1K Hold
56
﹤0.01% 550
2024
Q4
$4.63K Hold
56
﹤0.01% 517
2024
Q3
$4.01K Hold
56
﹤0.01% 512
2024
Q2
$3.83K Hold
56
﹤0.01% 490
2024
Q1
$3K Hold
56
﹤0.01% 570
2023
Q4
$2.98K Buy
+56
New +$2.73K ﹤0.01% 574

Other funds holding GMED

Tidemark's GMED Position: Q2 2026 in Review

Tidemark held its Globus Medical (GMED) position steady in Q2 2026 at 56 shares worth $4.42K. The position accounts for ﹤0.01% of the portfolio, ranked #613.

Tidemark first reported a position in GMED in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.89K in Q4 2025. 597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Tidemark held 56 shares of Globus Medical worth $4.42K as of Q2 2026.
  • Tidemark left its Globus Medical share count unchanged in Q2 2026.
  • Globus Medical made up ﹤0.01% of Tidemark's portfolio in Q2 2026, its #613 holding.
  • Tidemark first reported a position in Globus Medical in Q4 2023 and has held it in 11 quarters since.
  • Tidemark's Globus Medical position peaked at $4.89K in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.